Mifepristone Improves Weight Loss in Cushing’s Syndrome

Mifepristone improves weight loss in Cushing's syndrome
Mifepristone improves weight loss in Cushing’s syndrome
Patients with Cushing's syndrome who were administered oral mifepristone (Korlym) daily experienced significant, sustained weight loss over the years as they continued on the medication.

Fein, M.D., today presented new research showing that patients with Cushing’s syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease.

READ FULL ARTICLE Curated publisher From News Medical